337 related articles for article (PubMed ID: 33114139)
1. Regulation of Epithelial-Mesenchymal Plasticity by the E3 Ubiquitin-Ligases in Cancer.
Rodríguez-Alonso A; Casas-Pais A; Roca-Lema D; Graña B; Romay G; Figueroa A
Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33114139
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer.
Inoue Y; Itoh Y; Sato K; Kawasaki F; Sumita C; Tanaka T; Morishita D; Hayashi H
Curr Cancer Drug Targets; 2016; 16(2):110-8. PubMed ID: 26560121
[TBL] [Abstract][Full Text] [Related]
3. E3 Ubiquitin Ligases in Breast Cancer Metastasis: A Systematic Review of Pathogenic Functions and Clinical Implications.
Wang Y; Dai J; Zeng Y; Guo J; Lan J
Front Oncol; 2021; 11():752604. PubMed ID: 34745984
[TBL] [Abstract][Full Text] [Related]
4. E3 ubiquitin ligases as cancer targets and biomarkers.
Sun Y
Neoplasia; 2006 Aug; 8(8):645-54. PubMed ID: 16925947
[TBL] [Abstract][Full Text] [Related]
5. The roles of E3 ubiquitin ligases in cancer progression and targeted therapy.
Sampson C; Wang Q; Otkur W; Zhao H; Lu Y; Liu X; Piao HL
Clin Transl Med; 2023 Mar; 13(3):e1204. PubMed ID: 36881608
[TBL] [Abstract][Full Text] [Related]
6. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
[TBL] [Abstract][Full Text] [Related]
7. The emerging insight into E3 ligases as the potential therapeutic target for diabetic kidney disease.
Akhouri V; Majumder S; Gaikwad AB
Life Sci; 2023 May; 321():121643. PubMed ID: 36997061
[TBL] [Abstract][Full Text] [Related]
8. Two distinct E3 ligases, SCF
Liu J; Dong S; Wang H; Li L; Ye Q; Li Y; Miao J; Jhiang S; Zhao J; Zhao Y
FASEB J; 2019 Sep; 33(9):10538-10550. PubMed ID: 31238008
[TBL] [Abstract][Full Text] [Related]
9. Hakin-1, a New Specific Small-Molecule Inhibitor for the E3 Ubiquitin-Ligase Hakai, Inhibits Carcinoma Growth and Progression.
Martinez-Iglesias O; Casas-Pais A; Castosa R; Díaz-Díaz A; Roca-Lema D; Concha Á; Cortés Á; Gago F; Figueroa A
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32456234
[TBL] [Abstract][Full Text] [Related]
10. E3 ubiquitin ligase NEDD4L inhibits epithelial-mesenchymal transition by suppressing the β-catenin/HIF-1α positive feedback loop in chronic rhinosinusitis with nasal polyps.
Chen SY; Liu PQ; Qin DX; Lv H; Zhou HQ; Xu Y
Acta Pharmacol Sin; 2024 Apr; 45(4):831-843. PubMed ID: 38052867
[TBL] [Abstract][Full Text] [Related]
11. The SCF-type E3 Ubiquitin Ligases as Cancer Targets.
Kitagawa K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):119-29. PubMed ID: 26560120
[TBL] [Abstract][Full Text] [Related]
12. Proteomic Analysis of the E3 Ubiquitin-Ligase Hakai Highlights a Role in Plasticity of the Cytoskeleton Dynamics and in the Proteasome System.
Díaz-Díaz A; Casas-Pais A; Calamia V; Castosa R; Martinez-Iglesias O; Roca-Lema D; Santamarina I; Valladares-Ayerbes M; Calvo L; Chantada V; Figueroa A
J Proteome Res; 2017 Aug; 16(8):2773-2788. PubMed ID: 28675930
[TBL] [Abstract][Full Text] [Related]
13. E3 ubiquitin ligases in cancer and implications for therapies.
Wang D; Ma L; Wang B; Liu J; Wei W
Cancer Metastasis Rev; 2017 Dec; 36(4):683-702. PubMed ID: 29043469
[TBL] [Abstract][Full Text] [Related]
14. E3 Ubiquitin Ligases as Molecular Targets in Human Oral Cancers.
Masumoto K; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):130-5. PubMed ID: 26560119
[TBL] [Abstract][Full Text] [Related]
15. Novel Insights Into E3 Ubiquitin Ligase in Cancer Chemoresistance.
Yang L; Chen J; Huang X; Zhang E; He J; Cai Z
Am J Med Sci; 2018 Apr; 355(4):368-376. PubMed ID: 29661351
[TBL] [Abstract][Full Text] [Related]
16. SPSB3 targets SNAIL for degradation in GSK-3β phosphorylation-dependent manner and regulates metastasis.
Liu Y; Zhou H; Zhu R; Ding F; Li Y; Cao X; Liu Z
Oncogene; 2018 Feb; 37(6):768-776. PubMed ID: 29059170
[TBL] [Abstract][Full Text] [Related]
17. Essential Roles of E3 Ubiquitin Ligases in p53 Regulation.
Sane S; Rezvani K
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218667
[TBL] [Abstract][Full Text] [Related]
18. Role of E3 ubiquitin ligases in insulin resistance.
Yang XD; Xiang DX; Yang YY
Diabetes Obes Metab; 2016 Aug; 18(8):747-54. PubMed ID: 27097743
[TBL] [Abstract][Full Text] [Related]
19. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors.
Xu M; Zhu C; Zhao X; Chen C; Zhang H; Yuan H; Deng R; Dou J; Wang Y; Huang J; Chen Q; Jiang B; Yu J
Oncotarget; 2015 Jan; 6(2):979-94. PubMed ID: 25460509
[TBL] [Abstract][Full Text] [Related]
20. RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.
Uchida C; Kitagawa M
Curr Cancer Drug Targets; 2016; 16(2):157-74. PubMed ID: 26560116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
